Stryker Income Tax Expense from 2010 to 2024

SYK Stock  USD 390.14  4.46  1.16%   
Stryker Income Tax Expense yearly trend continues to be quite stable with very little volatility. Income Tax Expense may rise above about 533.4 M this year. From the period between 2010 and 2024, Stryker, Income Tax Expense regression line of its data series had sample variance of 225311.4 T and sample variance of 225311.4 T. View All Fundamentals
 
Income Tax Expense  
First Reported
1989-06-30
Previous Quarter
173 M
Current Value
209 M
Quarterly Volatility
154.3 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Stryker financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Stryker's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 B, Interest Expense of 373.8 M or Total Revenue of 21.5 B, as well as many indicators such as Price To Sales Ratio of 2.98, Dividend Yield of 0.0054 or PTB Ratio of 6.37. Stryker financial statements analysis is a perfect complement when working with Stryker Valuation or Volatility modules.
  
Check out the analysis of Stryker Correlation against competitors.
For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.

Latest Stryker's Income Tax Expense Growth Pattern

Below is the plot of the Income Tax Expense of Stryker over the last few years. It is Stryker's Income Tax Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Stryker's overall financial position and show how it may be relating to other accounts over time.
Income Tax Expense10 Years Trend
Very volatile
   Income Tax Expense   
       Timeline  

Stryker Income Tax Expense Regression Statistics

Arithmetic Mean300,606,667
Coefficient Of Variation157.90
Mean Deviation257,458,667
Median341,000,000
Standard Deviation474,669,805
Sample Variance225311.4T
Range2.2B
R-Value0.09
Mean Square Error240745.9T
R-Squared0.01
Significance0.75
Slope9,385,357
Total Sum of Squares3154359.9T

Stryker Income Tax Expense History

2024533.4 M
2023508 M
2022325 M
2021287 M
2020355 M
2019479 M
2018-1.2 B

About Stryker Financial Statements

Stryker investors utilize fundamental indicators, such as Income Tax Expense, to predict how Stryker Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Income Tax Expense508 M533.4 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:
Check out the analysis of Stryker Correlation against competitors.
For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.2
Dividend Share
3.2
Earnings Share
9.33
Revenue Per Share
57.728
Quarterly Revenue Growth
0.119
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.